A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt

PLoS Medicine

Volumn 7, Issue 5, 2010, Pages

  Ogilvie, Gina ^a   Anderson, Maureen ^b   Marra, Fawziah ^a   McNeil, Shelly ^c   Pielak, Karen ^b   Dawar, Meena ^a   Mcivor, Marilyn ^b   Ehlen, Thomas ^a   Dobson, Simon ^a   Money, Deborah ^a   Patrick, David M ^a   Naus, Monika ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; WART VIRUS VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CANADA; CHILD; DRUG PREFERENCE; FEMALE; FUNDING; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFORMATION SYSTEM; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PATIENT SAFETY; POPULATION RESEARCH; PREVENTIVE HEALTH SERVICE; SCHOOL CHILD; SCHOOL HEALTH SERVICE; SEXUAL BEHAVIOR; TREATMENT RESPONSE; WART VIRUS; ADULT; DECISION MAKING; EVALUATION; HEALTH CARE QUALITY; HEALTH CARE SURVEY; MALE; MIDDLE AGED; PAPILLOMA VIRUS; PARENT; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; RISK; SCHOOL; SOCIOECONOMICS; UTILIZATION REVIEW; VACCINATION;

ADULT; ATTITUDE TO HEALTH; BRITISH COLUMBIA; CHILD; DECISION MAKING; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM EVALUATION; SCHOOLS; SOCIOECONOMIC FACTORS; VACCINATION; YOUNG ADULT;

EID: 77953283498     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000270     Document Type: Article

References (31)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
2. Ault KA, Future II Study Group (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369: 1861-1868.
3. The Future II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N Engl J Med 356: 1915-1927.
4. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, et al. (2007) Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369: 2161-2170.
5. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, et al. (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369: 1693-1702.
6. Gunther OP, Ogilvie G, Naus M, Young E, Patrick DM, et al. (2008) Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity? J Infect Dis 197: 1653-1661.
7. Garnett GP, Kim JJ, French K, Goldie SJ (2006) Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 24: S178-S186.
8. Goldie SJ, Kim JJ, Myers E (2006) Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine 24: S164-S170.
9. Zimet GD (2005) Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 37: S17-S23.
10. Dempsey AF, Zimet GD, Davis RL, Koutsky L (2006) Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117: 1486-1493.
11. Marlow LAV, Waller J, Wardle J (2007) Parental attitudes to pre-pubertal HPV vaccination. Vaccine 25: 1945-1952.
12. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H (2005) Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 37: 248-251.
13. Davis K, Dickman ED, Ferris D, Dias JK (2004) Human papillomavirus vaccine acceptability among parents of 10-to 15-year-old adolescents. J Low Genit Tract Dis 8: 188-194.
14. Ogilvie GS, Remple VP, Marra F, McNeil S, Naus M, et al. (2007) Parental intention to have daughters receive the human papillomavirus vaccine. Can Med Assoc J 177: 1506-1512.
15. Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, et al. (2009) Mothers' intention for their daughters and themselves to receive the human papilloma-virus vaccine: a national study of nurses. Pediatrics 123: 1439-1445.
16. Christian WJ, Christian A, Hopenhayn C (2009) Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health 44: 437-445.
17. Constantine NA, Jerman P (2007) Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40: 108-115.
18. Woodhall SC, Lehtinen M, Verho T, Huhtala H, Hokkanen M, et al. (2007) Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health 40: 466-469.
19. Tricco AC, Anonychuk AM, Ng C, Pham B (2007) International acceptability of human papillomavirus vaccines: a systematic review. 24th International Papillomavirus Conference and Clinical Workshop; 3-9 November 2007; Beijing, China.
20. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, et al. (2008) Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: a prospective cohort study. BMJ 336: 1056.
21. Hankins M, French D, Horne R (2000) Statistical guidelines for studies of the theory of reasoned action and the theory of planned behaviour. Psychol Health 15: 151-161.
22. BC Stats, Government of British Columbia (2007) Population extrapolation for organization planning with less error, run cycle 32. Available: http://www.bcstats.gov.bc.ca/DATA/POP/pop/popproj.asp. Victoria, British Columbia: Ministry of Health, Government of British Columbia. Accessed 15 December 2008.
23. Rosner B (2000) Fundamentals of biostatistics. 5th edition. Pacific Grove (California): Thomson Higher Education.
24. Immunization Program BCfDC (2009) Immunization coverage rates, British Columbia. British Columbia Centre for Disease Control. Available: http://www.bccdc.org. Accessed 15 June 2009.
25. Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19: 531-538.
26. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, et al. (2008) Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 43: 239-245.
27. Dobson S, Deeks S, Money DM (2007) National Advisory Committee on Immunization Statement on Human Papillomavirus Vaccine. CCDR 33: 1-32.
28. Racine AD, Joyce TJ (2007) Maternal education, child immunizations, and public policy: evidence from the US National Immunization Survey. Soc Sci Med 65: 1765-1772.
29. Gullion JS, Henry L, Gullion G (2008) Deciding to opt out of childhood vaccination mandates. Public Health Nurs 25: 401-408.
30. Saewyc E, Taylor D, Homma Y, Ogilvie GS (2008) Trends in sexual health and risk behaviours among adolescent students in British Columbia. Can J Hum Sex 17: 1-14.
31. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N (2009) Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 360: 1981-1988.